Track the Cardinal Health, Inc stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was reported on 19 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Mary Scherer. The full history is accessible without an account.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cardinal Health, Inc Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,989 of 29,063 companies
18.5
score / 100
Value
24
Quality
13
FCF yld-3.8%
Earn yld-4.8%
EV/EBITDA·
ROE-40%
Gross mgn3.8%
Net mgn-0.1%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
11,650 shares@ US$235.7209100.0% of flowCommonSEC144:0001628280-26-057724
7 of 7 declarations
About Cardinal Health, Inc
Cardinal Health, Inc is an American company that specializes in the distribution of pharmaceuticals and medical devices. It also provides supply chain management services to healthcare institutions.